CL
Climb Bio, Inc. (CLYM)
NASDAQ·Healthcare·Biotechnology
$12.39
+4.91%
Mkt Cap $811.39M
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (10 analysts)
$21.67
Range $17.00 – $35.00
Implied Upside
+74.9%
Consensus $21.67 vs current $12.39
NASDAQ·Healthcare·Biotechnology
$12.39
+4.91%
Mkt Cap $811.39M
Buy
13
Hold
0
Sell
0
Price Target (10 analysts)
$21.67
Range $17.00 – $35.00
+74.9%
Consensus $21.67 vs current $12.39